CERE
Cerevel Therapeutics Holdings, Inc.
Director N Anthony Coles sold $2.1M of Cerevel Therapeutics Holdings, Inc.
Sold$2,057,890
$41.16Price
50,000Shares
−76%Stake
What CERE did after the filing
- The stock from Mon, Mar 4 close, $41.09
- +0.5%
- S&P 500, same days
- −1.4%
Measured over 30 trading days, to the Apr 16 close.
Traded Thu, Feb 29. Filed Mon, Mar 4, 12:49 PM ET, during the session. Returns use the Mar 4 close and the Apr 16 close. Not investment advice.